WHO Approves Abbott’s Breakthrough HIV Diagnosis Technology

ABBOTT’s HIV Point-of Care Test technology, the m-PIMA™ HIV-1/2 VL has become the world’s first point of care viral load diagnostic test to receive the World Health Organisation (WHO) prequalification approval (WHO PQ). HealthTimes Reporter The development comes after it emerged after rigorous tests and trails which proved that Abbott’s technology meets global standards of quality, safety and efficiency. The test received CE Mark in December 2018. “m-PIMA HIV-1/2 VL is the only truly portable molecular point-of-care test designed specifically for use in resource-limited settings such as in sub-Saharan Africa,”…

Share
Read More